 Laura Hurley
Concepts (226)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vaccination | 44 | 2026 | 1467 | 3.890 |
Why?
| | Physicians, Primary Care | 16 | 2024 | 225 | 3.860 |
Why?
| | Practice Patterns, Physicians' | 25 | 2024 | 1328 | 2.400 |
Why?
| | Attitude of Health Personnel | 28 | 2024 | 1175 | 2.300 |
Why?
| | Influenza Vaccines | 16 | 2025 | 551 | 2.110 |
Why?
| | Pneumococcal Vaccines | 7 | 2025 | 138 | 2.080 |
Why?
| | Vaccines | 14 | 2025 | 405 | 2.080 |
Why?
| | Health Knowledge, Attitudes, Practice | 13 | 2025 | 1395 | 2.050 |
Why?
| | Herpes Zoster Vaccine | 7 | 2022 | 160 | 1.890 |
Why?
| | Physicians, Family | 11 | 2021 | 192 | 1.540 |
Why?
| | Influenza, Human | 11 | 2023 | 625 | 1.360 |
Why?
| | Herpes Zoster | 4 | 2022 | 319 | 1.340 |
Why?
| | Vaccination Coverage | 3 | 2026 | 98 | 1.290 |
Why?
| | Health Care Surveys | 13 | 2021 | 562 | 1.200 |
Why?
| | Self Report | 6 | 2026 | 858 | 1.090 |
Why?
| | Immunization | 8 | 2021 | 405 | 1.080 |
Why?
| | Surveys and Questionnaires | 24 | 2025 | 5931 | 0.970 |
Why?
| | Papillomavirus Vaccines | 8 | 2021 | 317 | 0.970 |
Why?
| | Immunization, Secondary | 1 | 2025 | 92 | 0.890 |
Why?
| | Immunization Schedule | 9 | 2021 | 202 | 0.890 |
Why?
| | Primary Health Care | 10 | 2024 | 1756 | 0.850 |
Why?
| | Physicians | 10 | 2022 | 928 | 0.850 |
Why?
| | Papillomavirus Infections | 5 | 2021 | 363 | 0.820 |
Why?
| | Respiratory Syncytial Virus Vaccines | 2 | 2025 | 38 | 0.800 |
Why?
| | Guideline Adherence | 4 | 2024 | 553 | 0.790 |
Why?
| | Vaccines, Synthetic | 2 | 2022 | 138 | 0.740 |
Why?
| | Asthma | 6 | 2025 | 1919 | 0.740 |
Why?
| | Respiratory Syncytial Virus Infections | 2 | 2025 | 131 | 0.740 |
Why?
| | Respiratory Function Tests | 1 | 2024 | 560 | 0.730 |
Why?
| | Pediatricians | 7 | 2022 | 131 | 0.730 |
Why?
| | Adult | 47 | 2026 | 39134 | 0.730 |
Why?
| | Diphtheria-Tetanus-acellular Pertussis Vaccines | 4 | 2019 | 96 | 0.730 |
Why?
| | General Practitioners | 2 | 2021 | 26 | 0.700 |
Why?
| | Internal Medicine | 5 | 2014 | 273 | 0.700 |
Why?
| | Middle Aged | 42 | 2026 | 34487 | 0.660 |
Why?
| | Insurance, Health, Reimbursement | 4 | 2018 | 97 | 0.650 |
Why?
| | Reminder Systems | 3 | 2018 | 174 | 0.640 |
Why?
| | Vaccination Refusal | 5 | 2021 | 70 | 0.640 |
Why?
| | Patient Protection and Affordable Care Act | 2 | 2016 | 101 | 0.600 |
Why?
| | United States | 37 | 2026 | 15195 | 0.570 |
Why?
| | Family Practice | 10 | 2017 | 440 | 0.560 |
Why?
| | Pneumococcal Infections | 2 | 2018 | 108 | 0.540 |
Why?
| | Humans | 81 | 2026 | 140898 | 0.530 |
Why?
| | Immunization Programs | 6 | 2020 | 221 | 0.520 |
Why?
| | Practice Guidelines as Topic | 8 | 2024 | 1536 | 0.510 |
Why?
| | Female | 51 | 2026 | 75540 | 0.500 |
Why?
| | Male | 45 | 2025 | 69893 | 0.470 |
Why?
| | Clinical Competence | 3 | 2018 | 1196 | 0.460 |
Why?
| | Aged | 19 | 2025 | 24666 | 0.440 |
Why?
| | Data Mining | 2 | 2025 | 115 | 0.420 |
Why?
| | Preventive Health Services | 1 | 2016 | 154 | 0.420 |
Why?
| | Pediatrics | 11 | 2021 | 1097 | 0.410 |
Why?
| | Insurance, Health | 1 | 2016 | 298 | 0.400 |
Why?
| | Diabetes Mellitus | 1 | 2022 | 1072 | 0.400 |
Why?
| | Meningococcal Vaccines | 3 | 2018 | 64 | 0.360 |
Why?
| | Mumps | 2 | 2022 | 24 | 0.350 |
Why?
| | Anti-Asthmatic Agents | 2 | 2025 | 273 | 0.330 |
Why?
| | Health Services Research | 2 | 2018 | 402 | 0.320 |
Why?
| | Medicare Part D | 1 | 2010 | 25 | 0.320 |
Why?
| | Age Factors | 8 | 2021 | 3278 | 0.320 |
Why?
| | Electronic Health Records | 4 | 2026 | 1125 | 0.310 |
Why?
| | Clinical Decision-Making | 3 | 2021 | 339 | 0.300 |
Why?
| | Rotavirus Vaccines | 3 | 2021 | 42 | 0.290 |
Why?
| | Nephrology | 1 | 2009 | 61 | 0.290 |
Why?
| | Young Adult | 9 | 2026 | 13646 | 0.280 |
Why?
| | Neuralgia, Postherpetic | 1 | 2008 | 40 | 0.270 |
Why?
| | Minority Groups | 1 | 2010 | 277 | 0.270 |
Why?
| | Gynecology | 3 | 2019 | 178 | 0.270 |
Why?
| | Rotavirus Infections | 2 | 2021 | 39 | 0.270 |
Why?
| | Adverse Drug Reaction Reporting Systems | 2 | 2025 | 80 | 0.270 |
Why?
| | Cross-Sectional Studies | 6 | 2026 | 5645 | 0.260 |
Why?
| | Adrenal Cortex Hormones | 3 | 2025 | 501 | 0.250 |
Why?
| | Emigrants and Immigrants | 1 | 2009 | 149 | 0.250 |
Why?
| | Safety-net Providers | 2 | 2025 | 124 | 0.250 |
Why?
| | Medicaid | 3 | 2025 | 446 | 0.230 |
Why?
| | Meningococcal Infections | 2 | 2018 | 30 | 0.230 |
Why?
| | Colorado | 5 | 2025 | 4597 | 0.230 |
Why?
| | Vaccines, Conjugate | 2 | 2018 | 63 | 0.230 |
Why?
| | Pregnancy Complications, Infectious | 2 | 2020 | 406 | 0.220 |
Why?
| | Professional-Family Relations | 2 | 2016 | 152 | 0.210 |
Why?
| | Physician-Patient Relations | 3 | 2019 | 580 | 0.210 |
Why?
| | Adolescent | 13 | 2025 | 22027 | 0.210 |
Why?
| | Health Expenditures | 1 | 2025 | 193 | 0.210 |
Why?
| | Tinnitus | 1 | 2024 | 60 | 0.200 |
Why?
| | Respiratory Syncytial Virus, Human | 2 | 2025 | 77 | 0.190 |
Why?
| | Kidney Failure, Chronic | 1 | 2009 | 599 | 0.190 |
Why?
| | Pregnancy | 7 | 2026 | 7035 | 0.190 |
Why?
| | Beclomethasone | 1 | 2022 | 9 | 0.190 |
Why?
| | Behavioral Risk Factor Surveillance System | 1 | 2022 | 53 | 0.190 |
Why?
| | Rubella | 1 | 2022 | 23 | 0.180 |
Why?
| | Neisseria meningitidis, Serogroup B | 2 | 2018 | 18 | 0.180 |
Why?
| | Measles | 1 | 2022 | 48 | 0.180 |
Why?
| | Herpesvirus 3, Human | 2 | 2019 | 336 | 0.170 |
Why?
| | Child | 15 | 2025 | 22313 | 0.170 |
Why?
| | Rural Population | 1 | 2025 | 605 | 0.170 |
Why?
| | Refusal to Treat | 1 | 2020 | 16 | 0.170 |
Why?
| | Insurance Coverage | 3 | 2018 | 239 | 0.160 |
Why?
| | Standing Orders | 1 | 2020 | 11 | 0.160 |
Why?
| | Norovirus | 1 | 2020 | 26 | 0.160 |
Why?
| | Advisory Committees | 1 | 2021 | 214 | 0.160 |
Why?
| | Policy | 1 | 2020 | 145 | 0.150 |
Why?
| | Gastroenteritis | 1 | 2020 | 68 | 0.150 |
Why?
| | Obstetrics | 2 | 2019 | 176 | 0.150 |
Why?
| | Cost of Illness | 2 | 2018 | 310 | 0.150 |
Why?
| | Evidence-Based Medicine | 2 | 2020 | 712 | 0.150 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2020 | 151 | 0.140 |
Why?
| | Administration, Inhalation | 3 | 2025 | 594 | 0.140 |
Why?
| | Awareness | 1 | 2018 | 102 | 0.140 |
Why?
| | Cardiovascular Diseases | 1 | 2010 | 2082 | 0.140 |
Why?
| | Professional Practice | 1 | 2018 | 62 | 0.140 |
Why?
| | Glucocorticoids | 1 | 2022 | 533 | 0.130 |
Why?
| | Patients | 1 | 2018 | 179 | 0.130 |
Why?
| | Hepatitis A | 1 | 2017 | 26 | 0.130 |
Why?
| | Health Plan Implementation | 1 | 2018 | 142 | 0.130 |
Why?
| | Information Systems | 1 | 2016 | 60 | 0.120 |
Why?
| | Physician's Role | 2 | 2019 | 217 | 0.120 |
Why?
| | Quality of Life | 3 | 2023 | 3005 | 0.120 |
Why?
| | Directive Counseling | 1 | 2016 | 46 | 0.120 |
Why?
| | Text Messaging | 1 | 2018 | 179 | 0.120 |
Why?
| | Parents | 4 | 2021 | 1440 | 0.110 |
Why?
| | Self-Management | 1 | 2018 | 199 | 0.110 |
Why?
| | Treatment Refusal | 1 | 2015 | 96 | 0.110 |
Why?
| | Attitude to Health | 1 | 2017 | 451 | 0.110 |
Why?
| | Chi-Square Distribution | 2 | 2018 | 521 | 0.100 |
Why?
| | Patient Acceptance of Health Care | 3 | 2016 | 876 | 0.100 |
Why?
| | Infant | 7 | 2025 | 9790 | 0.100 |
Why?
| | Medicare | 2 | 2018 | 806 | 0.100 |
Why?
| | Documentation | 1 | 2015 | 193 | 0.100 |
Why?
| | Health Care Costs | 1 | 2017 | 418 | 0.100 |
Why?
| | Health Surveys | 2 | 2018 | 511 | 0.100 |
Why?
| | Neoplastic Stem Cells | 1 | 2017 | 407 | 0.100 |
Why?
| | Medically Uninsured | 1 | 2014 | 136 | 0.100 |
Why?
| | Tumor Microenvironment | 1 | 2017 | 699 | 0.100 |
Why?
| | Interdisciplinary Communication | 1 | 2014 | 191 | 0.100 |
Why?
| | Aged, 80 and over | 3 | 2025 | 7899 | 0.100 |
Why?
| | Fibroblasts | 1 | 2017 | 1017 | 0.090 |
Why?
| | Neisseria meningitidis | 1 | 2011 | 25 | 0.090 |
Why?
| | Safety | 1 | 2013 | 356 | 0.080 |
Why?
| | Fees, Pharmaceutical | 1 | 2010 | 9 | 0.080 |
Why?
| | Product Surveillance, Postmarketing | 2 | 2025 | 68 | 0.080 |
Why?
| | Internet | 2 | 2019 | 682 | 0.080 |
Why?
| | Data Collection | 4 | 2014 | 651 | 0.070 |
Why?
| | Hepatitis B Vaccines | 1 | 2009 | 43 | 0.070 |
Why?
| | Mexican Americans | 1 | 2010 | 112 | 0.070 |
Why?
| | Hepatitis B | 1 | 2009 | 67 | 0.070 |
Why?
| | Referral and Consultation | 1 | 2014 | 794 | 0.070 |
Why?
| | ROC Curve | 1 | 2010 | 589 | 0.070 |
Why?
| | Regression Analysis | 2 | 2020 | 1015 | 0.070 |
Why?
| | Kaplan-Meier Estimate | 1 | 2010 | 907 | 0.070 |
Why?
| | Electronic Mail | 2 | 2018 | 65 | 0.070 |
Why?
| | Health Personnel | 3 | 2019 | 724 | 0.060 |
Why?
| | Costs and Cost Analysis | 2 | 2018 | 219 | 0.060 |
Why?
| | Proportional Hazards Models | 1 | 2010 | 1261 | 0.060 |
Why?
| | Kidney Diseases | 1 | 2009 | 408 | 0.060 |
Why?
| | Renal Dialysis | 1 | 2009 | 457 | 0.060 |
Why?
| | Risk Assessment | 2 | 2015 | 3484 | 0.060 |
Why?
| | Predictive Value of Tests | 1 | 2010 | 2062 | 0.050 |
Why?
| | Seasons | 2 | 2020 | 542 | 0.050 |
Why?
| | Vaccines, Combined | 1 | 2023 | 49 | 0.050 |
Why?
| | Nebulizers and Vaporizers | 1 | 2023 | 68 | 0.050 |
Why?
| | Bacterial Vaccines | 1 | 2023 | 63 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2024 | 415 | 0.050 |
Why?
| | Symptom Flare Up | 1 | 2022 | 38 | 0.050 |
Why?
| | Time Factors | 2 | 2010 | 6944 | 0.050 |
Why?
| | Measles-Mumps-Rubella Vaccine | 1 | 2022 | 47 | 0.050 |
Why?
| | Incidence | 2 | 2024 | 2782 | 0.050 |
Why?
| | Delivery of Health Care | 1 | 2009 | 949 | 0.050 |
Why?
| | Mumps Vaccine | 1 | 2021 | 12 | 0.050 |
Why?
| | Kidney | 1 | 2009 | 1475 | 0.040 |
Why?
| | Risk Factors | 3 | 2010 | 10430 | 0.040 |
Why?
| | Hypertension | 1 | 2009 | 1251 | 0.040 |
Why?
| | Vaccines, Inactivated | 1 | 2021 | 68 | 0.040 |
Why?
| | Vaccines, Attenuated | 1 | 2021 | 130 | 0.040 |
Why?
| | Qualitative Research | 2 | 2018 | 1525 | 0.040 |
Why?
| | Pragmatic Clinical Trials as Topic | 1 | 2020 | 126 | 0.040 |
Why?
| | Child, Preschool | 3 | 2025 | 11462 | 0.040 |
Why?
| | Attitude | 1 | 2021 | 257 | 0.040 |
Why?
| | Cohort Studies | 2 | 2025 | 5789 | 0.040 |
Why?
| | Pandemics | 2 | 2021 | 1643 | 0.040 |
Why?
| | Disease Outbreaks | 1 | 2022 | 418 | 0.040 |
Why?
| | Postal Service | 1 | 2018 | 30 | 0.040 |
Why?
| | Serogroup | 1 | 2018 | 45 | 0.040 |
Why?
| | Pharmacists | 1 | 2021 | 255 | 0.040 |
Why?
| | Diphtheria | 1 | 2017 | 22 | 0.030 |
Why?
| | Tetanus | 1 | 2017 | 27 | 0.030 |
Why?
| | Whooping Cough | 1 | 2017 | 55 | 0.030 |
Why?
| | Research Design | 1 | 2024 | 1104 | 0.030 |
Why?
| | Population Groups | 1 | 2017 | 58 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2020 | 1496 | 0.030 |
Why?
| | Professional Practice Gaps | 1 | 2016 | 14 | 0.030 |
Why?
| | Equipment and Supplies | 1 | 2015 | 34 | 0.030 |
Why?
| | Mice, Nude | 1 | 2017 | 689 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2023 | 2822 | 0.030 |
Why?
| | Hospitalization | 1 | 2025 | 2261 | 0.030 |
Why?
| | Focus Groups | 1 | 2017 | 567 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2017 | 1271 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2020 | 1598 | 0.030 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2017 | 265 | 0.030 |
Why?
| | Sex Factors | 1 | 2019 | 2051 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2021 | 2920 | 0.030 |
Why?
| | Circovirus | 1 | 2013 | 6 | 0.020 |
Why?
| | Communication | 1 | 2019 | 948 | 0.020 |
Why?
| | Life Style | 1 | 2015 | 478 | 0.020 |
Why?
| | Intussusception | 1 | 2013 | 26 | 0.020 |
Why?
| | Drug Contamination | 1 | 2013 | 51 | 0.020 |
Why?
| | Societies, Medical | 1 | 2017 | 852 | 0.020 |
Why?
| | Decision Support Systems, Clinical | 1 | 2016 | 263 | 0.020 |
Why?
| | Professional Practice Location | 1 | 2011 | 28 | 0.020 |
Why?
| | Community-Institutional Relations | 1 | 2012 | 102 | 0.020 |
Why?
| | Health Services Accessibility | 1 | 2019 | 1020 | 0.020 |
Why?
| | Swine | 1 | 2013 | 809 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2025 | 11125 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 4199 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2017 | 1999 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2021 | 6257 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2017 | 3487 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2018 | 5194 | 0.020 |
Why?
| | Diabetes Complications | 1 | 2009 | 222 | 0.020 |
Why?
| | Vascular Diseases | 1 | 2009 | 244 | 0.020 |
Why?
| | Risk-Taking | 1 | 2009 | 341 | 0.020 |
Why?
| | Glomerular Filtration Rate | 1 | 2009 | 752 | 0.010 |
Why?
| | Logistic Models | 1 | 2009 | 2088 | 0.010 |
Why?
| | Chronic Disease | 1 | 2009 | 1811 | 0.010 |
Why?
| | Animals | 2 | 2017 | 37579 | 0.010 |
Why?
| | Mice | 1 | 2017 | 18057 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2009 | 16315 | 0.010 |
Why?
|
|
Hurley's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|